TDTohru Dairi

Tohru Dairi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tohru Dairi has a total of 368 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Structural and biochemical analyses of a lasso peptide natural product containing an unusual disulfide bond between consecutive cysteines

    by Atsushi Kawakami, Takeshi Tsunoda, Hiroyuki Kumeta, Chitose Maruyama, Yoshimitsu Hamano, Tohru Dairi, Yasushi Ogasawara

    Lasso peptides are a group of ribosomally synthesized and posttranslationally modified peptides with a unique lariat topology. They have been classified into four classes based on disulfide bond patterns. In this study, we isolated a lasso peptide containing a disulfide bond in the macrocyclic ring, which is identical to jiangxilassin A. Analysis of the three-dimensional solution structure of this peptide suggested that the disulfide bond enhances the rigidity of the macrocyclic ring. To investigate whether the disulfide bond is required for enzymatic modification, we replaced either cysteine residue with serine. Upon heterologous expression, both mutants produced disulfide-linked dimers that retained macrolactam ring formation, dehydration, and methylation, although their production levels were substantially lower than the level observed for the wild type. These results indicate that the vicinal disulfide bond is not strictly required for these posttranslational modifications but contributes to the efficient production of jiangxilassin A.

  • Enzymatic skeletal editing reaction forming the 1,3,5-triazine core during biosynthesis of the anticancer nucleoside analogue 5-azacytidine

    by Akari Umezawa, Takeshi Tsunoda, Yu Nakashima, Yung-Lin Wang, Tomoki Yoneda, Chitose Maruyama, Ning-Shian Hsu, Taro Matsuyama, Kazunori Miyamoto, Hajime Sato, et al.

  • tRNA-Dependent Chemoenzymatic Transformation of Aminoacyl Pendant Moieties of Streptothricin Antibiotics

    by Chitose Maruyama, Yu Nakashima, Kanki Matsuda, Sherif A. Hamdy, Shun Uchiyama, Yuki Goto, Takahiro Mori, Yasushi Ogasawara, Kazuo Shin-Ya, Ikuro Abe, et al.

    Streptothricin (ST) antibiotics are promising agents against multidrug-resistant pathogens and are structurally classified into two groups, containing either a β-lysyl or a glycyl pendant moiety attached via an amide bond to an amino sugar core. These pendant moieties are essential determinants of the biological activity and selective toxicity of ST antibiotics. We previously demonstrated that during ST biosynthesis, the β-lysyl pendant moiety is installed by nonribosomal peptide synthetases, whereas the glycyl pendant moiety is generated by a Gly-tRNAGly-dependent amide-forming enzyme. Here, we present a chemoenzymatic approach to transform aminoacyl pendant moieties using the promiscuous tRNA-dependent amide-forming enzyme Sba18. Remarkably, Sba18 generates two new ST derivatives, alanylthricin and serylthricin, by utilizing Ala-tRNAAla and Ser-tRNASer, respectively. Moreover, Sba18 accepts aminoacyl-tRNA mimics prepared by flexizyme-mediated charging of chemically synthesized aminoacyl groups and produces additional 11 ST derivatives. Alanylthricin and serylthricin retain antibiotic activity, demonstrating that this tRNA-dependent chemoenzymatic approach provides a viable strategy for expanding the structural diversity of streptothricin antibiotics. Furthermore, structural comparison of Sba18 with its Gly-tRNAGly-specific orthologue Sbb17 elucidates the catalytic and substrate-recognition mechanisms underlying the broad specificity of Sba18. These structural insights provide a foundation for expanding the structural diversity not only of ST antibiotics but also of other peptide natural products biosynthesized using aminoacyl-tRNAs.

  • Open Access

    Functional Analysis of Three Dehydratase Domains, DH PKS , DH1 FabA , and DH2 FabA , in Microalgal Docosahexaenoic Acid Synthase

    by Tomoya Kawata, Hiyu Kobayashi, Makoto Otsuka, Chitose Maruyama, Yoshimitsu Hamano, Takeshi Tsunoda, Yasushi Ogasawara, Tohru Dairi

    Schizochytrium sp., a eukaryotic microalga, biosynthesizes docosahexaenoic acid (DHA; C22:6 ω 3) by DHA synthase, which is composed of three subunits (OrfA to C) possessing multiple catalytic domains. The enzyme has three dehydratase (DH) domains, DH PKS in OrfA and tandem DH FabA (DH1 FabA and DH2 FabA ) domains in OrfC. In this study, the function of each of the DH domains was investigated by in vivo heterologous expression experiments in Escherichia coli and in vitro studies with recombinant truncated OrfA containing DH PKS and full‐length OrfC, in which one of the tandem DH FabA domains was inactivated by site‐directed mutagenesis, and acyl–acyl carrier protein (ACP) intermediates. Following heterologous expression, the DH1 FabA ‐ or DH2 FabA ‐inactivated enzyme produced no DHA, revealing that both domains are essential, while the DH PKS ‐inactivated enzyme showed significantly reduced DHA productivity, confirming that DH PKS is required for full production of DHA. Moreover, in vitro experiments showed that the C4‐ACP substrate was accepted by all of the DHs, but DH PKS and DH2 FabA showed higher activities than DH1 FabA . DH1 FabA catalyzed two types of reactions: (de)hydrations of C10‐, C16‐, and C22‐ACP substrates and (de)hydrations/2‐ trans to 2‐ cis isomerization of C8‐, C14‐, and C20‐ACP substrates. By contrast, DH2 FabA catalyzed (de)hydrations/2‐ trans to 3‐ cis isomerization of C6‐, C12‐, and C18‐ACP substrates.

  • Identification of peptaibols as specific inhibitors of the futalosine pathway

    by Marie Kikuchi, Haruka Kiyanagi, Takeshi Tsunoda, Yuki Inahashi, Kenichi Nonaka, Tohru Dairi, Yasushi Ogasawara

    Menaquinone is an indispensable cofactor in the electron-transfer pathway for most Gram-positive bacteria. While most bacteria biosynthesize menaquinone by the well-known canonical pathway, some bacteria including Helicobacter pylori, which is a pathogen causing stomach cancer, use the futalosine pathway. Because beneficial intestinal bacteria such as lactobacilli use the canonical pathway, the futalosine pathway will be a great target for developing antibiotics specific to H. pylori. In this study, we searched for such metabolites from actinomycetes and fungi and identified 4 new peptaibols from culture broth of Verruciconidia sp. FKI-8918 as specific inhibitors of the futalosine pathway.

  • Open Access

    Substrate specificities of two ketosynthases in eukaryotic microalgal and prokaryotic marine bacterial DHA synthases

    by Kaito Ogata, Riku Nakama, Hiyu Kobayashi, Tomoya Kawata, Chitose Maruyama, Takeshi Tsunoda, Tetsuro Ujihara, Yoshimitsu Hamano, Yasushi Ogasawara, Tohru Dairi

    Highly reducing iterative polyketide synthases (HR-iPKSs) are huge enzyme complexes with multiple catalytic domains that biosynthesize polyketides by intrinsically programmed iterative carbon chain extensions and reductions. Unlike most HR-iPKSs, which possess a single ketosynthase (KS) domain for all carbon chain elongations, polyunsaturated fatty acid (PUFA) synthases contain two KS domains. We previously examined the substrate specificities of two KS domains of prokaryotic marine PUFA synthases with several acyl-ACP intermediates and showed that the two KS domains are utilized differentially depending on the carbon chain length. In this study, we investigated two KS domains in a eukaryotic microalgal DHA synthase, KS A and KS B , which show low similarities to those of prokaryotic marine enzymes, together with almost all the acyl-ACP intermediates. C6-, C12-, and C18-ACPs were exclusively accepted by KS A while KS B utilized C-8. C14- and C20-ACPs. In contrast, both KS A and KS B showed activities against C2-, C4-, and C10-ACPs. A general tendency was observed in which both the prokaryotic KS and the eukaryotic KS recognized the acyl structures in the vicinity of the thioester in ACP substrates except for short-chain substrates.


  • Open Access

    Biosynthesis of lactacystin as a proteasome inhibitor

    by Takeshi Tsunoda, Shunkichi Furumura, Haruka Yamazaki, Chitose Maruyama, Yoshimitsu Hamano, Yasushi Ogasawara, Tohru Dairi

    Lactacystin is an irreversible proteasome inhibitor isolated from Streptomyces lactacystinicus. Despite its importance for its biological activity, the biosynthesis of lactacystin remains unknown. In this study, we identified the lactacystin biosynthetic gene cluster by gene disruption and heterologous expression experiments. We also examined the functions of the genes encoding a PKS/NRPS hybrid protein (LctA), NRPS (LctB), ketosynthase-like cyclase (LctC), cytochrome P450 (LctD), MbtH-like protein (LctE), and formyltransferase (LctF) by in vivo and in vitro experiments. In particular, we demonstrated that LctF directly transferred the formyl group of 10-N-formyl tetrahydrofolate to CoA. The formyl group of formyl-CoA was then transferred to ACP1 by LctA_AT1 to form formyl-ACP1. This is the first example of an AT domain recognizing a formyl group. The formyl group is perhaps transferred to methylmalonate tethered on LctA_ACP2 to yield methylmalonyl-semialdehyde-ACP2. Then, it would be condensed with leucine bound to PCP in LctB by the C domain in LctA. Using a mimic compound, we confirmed that LctC catalyzed the formation of the cyclic α,α-disubstituted amino acid structure with concomitant release of the product from PCP. Thus, we figured out the overall biosynthesis of lactacystin including a novel role of a formyl group in a secondary metabolite.


  • Identification of a new oligomycin derivative as a specific inhibitor of the alternative peptidoglycan biosynthetic pathway

    by Shuhei Umetsu, Takeshi Tsunoda, Haruka Kiyanagi, Yuki Inahashi, Kenichi Nonaka, Tohru Dairi, Yasushi Ogasawara

    Peptidoglycan is an important macromolecule in bacterial cell walls to maintain cell integrity, and its biosynthetic pathway has been well studied. Recently, we demonstrated that some bacteria such as Xanthomonas oryzae, a pathogen causing bacterial blight of rice, used an alternative pathway for peptidoglycan biosynthesis. In this pathway, MurD2, a MurD homolog, catalyzed the attachment of l-Glu to UDP-MurNAc-l-Ala and MurL, which did not show homology to any known protein, catalyzed epimerization of the terminal l-Glu of the MurD2 product to generate UDP-MurNAc-l-Ala-d-Glu. Because the alternative pathway also operates in some other plant pathogens and opportunistic pathogens, specific inhibitors of the alternative pathway could function as pesticides and antibiotics for these pathogens. In this study, we searched for specific inhibitors of the alternative pathway from metabolites produced by actinomycetes and identified a new oligomycin-class polyketide, which was revealed to inhibit the MurD2 reaction, in culture broth of Micromonospora sp. K18-0097.